Soft tissue calcification in chronic dialysis patients
- PMID: 836675
- PMCID: PMC2032079
Soft tissue calcification in chronic dialysis patients
Abstract
Autopsy protocols and microscopic slides of 56 dialyzed and 18 nondialyzed chronically uremic patients were reviewed to assess the presence, extent, and severity of extraosseous soft tissue calcification. Calcification was identified in 79% of the dialysis patients and 44% of the nondialysis patients (P iss less than .025). Soft tissue calcification most frequently involved the heart, lungs, stomach, and kidneys. Lesions were severe in 36% of the dialysis patients and, when strategically located within the myocardium, were life-threatening. The deaths of 6 dialysis patients were attributed to severe calcification of the cardiac conduction system and/or myocardium. The presence and severity of soft tissue calcification was not related to duration of dialysis, patients' age, degree of parathyroid gland hyperplasia, radiographic evidence of soft tissue calcification, serum calcium and phosphate levels, Ca X P products, or type or severity of metabolic bone disease.
Similar articles
-
Metabolic bone disease in chronic renal failure. I. Dialyzed uremics.Am J Pathol. 1975 Mar;78(3):365-84. Am J Pathol. 1975. PMID: 1119535 Free PMC article.
-
Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.Kidney Int. 2003 Nov;64(5):1653-61. doi: 10.1046/j.1523-1755.2003.00284.x. Kidney Int. 2003. PMID: 14531797
-
Intracardiac calcification in patients under chronic haemodialysis.Int Urol Nephrol. 1987;19(4):441-6. doi: 10.1007/BF02550363. Int Urol Nephrol. 1987. PMID: 3429168
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.J Ren Nutr. 2006 Apr;16(2):100-18. doi: 10.1053/j.jrn.2006.01.006. J Ren Nutr. 2006. PMID: 16567266 Review.
Cited by
-
Risk factors and implications associated with renal mineralization in chronic kidney disease in cats.J Vet Intern Med. 2022 Mar;36(2):634-646. doi: 10.1111/jvim.16363. Epub 2022 Jan 19. J Vet Intern Med. 2022. PMID: 35043997 Free PMC article.
-
Medullary nephrocalcinosis in nephropathic cystinosis.Pediatr Nephrol. 1995 Aug;9(4):412-8. doi: 10.1007/BF00866713. Pediatr Nephrol. 1995. PMID: 7577398 Clinical Trial.
-
The calcium channel blocker nisoldipine delays progression of chronic renal failure in humans (preliminary communication).Cardiovasc Drugs Ther. 1988 Jan;1(5):523-8. doi: 10.1007/BF02125735. Cardiovasc Drugs Ther. 1988. PMID: 3154680 Clinical Trial.
-
Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.Eur J Nucl Med. 1991;18(10):839-55. doi: 10.1007/BF00175066. Eur J Nucl Med. 1991. PMID: 1743208 Review.
-
Early degeneration of porcine xenograft valves in pediatric patients who have undergone apico-aortic bypass.Tex Heart Inst J. 1982 Mar;9(1):41-7. Tex Heart Inst J. 1982. PMID: 15226810 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources